Mesorhizobium muleiense

Bacteria
General | Carbohydrate O/F | Substrate utilisation | Enzymes | Metabolites | Antibiotics

Overview

  • Mesorhizobium muleiense is a Gram-negative, non-spore-forming, aerobic, motile, rod-shaped bacterium. It has been detected in at least 1 gut microbiome compilation study or metastudy. The DNA G+C content is 61.2%. Mesorhizobium muleiense is likely to be transient and not a long-term gut coloniser. (Zhang2012a)



  • This organism has been recovered from chickpea rhizobia, China. Pathogenicity status unknown, or very unlikely to be pathogenic. Likely to be transient and not a long-term gut commensal.
    • QUIRKS
  • Aerobic and optimum growth temperature of 28C suggests this is an unlikely gut coloniser.
    • GENERAL CHARACTERISTICS (Zhang2012a);
    Character Response
  • 🧂
  • Salt tolerance:
  • doesn't tolerate 1% salt;
  • pH
  • Acidity tolerance:
  • tolerates pH 6.0; tolerates pH 9.0; Grows optimally at pH 6-8.
  • 🌡
  • Temperature tolerance:
  • doesn't grow at 37℃; Grows optimally at 28℃.
  • ⥅
  • Substrates assimilated or utilised:
  • arabinose; L-arabinose; erythritol; fructose; galactose; gluconate; glucose; inulin; lactose; mannose; rhamnose; ribose; sorbitol; sucrose; trehalose; xylose; D-alanine; arginine; cysteine; isoleucine; lysine; methionine; proline; threonine; valine; acetate;
  • Active enzymes:
  • catalase;
    • SPECIAL FEATURES (Zhang2012a);
    Character Response
  • ✗
  • Metabolites not produced:
  • H₂S;
  • ✗
  • VP test:
  • not active
  • ✗
  • Nitrate:
  • not reduced
    • RESPONSE TO ANTIBIOTICS (Zhang2012a);
    Class Active Resistant
  • Penicillins:
  • ampicillin;
  • Macrolides:
  • erythromycin;
  • Tetracyclines:
  • tetracycline;
  • Aminoglycosides:
  • neomycin; spectinomycin; streptomycin;
  • gentamicin; kanamycin;

    • Details

    GENERAL
    Lineage Physiology General Growth Tolerances Hydrol./digest./degr.
    Phylum:  Proteobacteria Class:  Alphaproteobacteria Order:  Rhizobiales Family:  Phyllobacteriaceae Genus:  Mesorhizobium Gram stain:  neg O2 Relation.:  aerobic Spore:  No spore Motility:  Swimming Morphology:  Rod
    Health:  Unknown
    Source:  chickpea rhizobia, China
    DNA G+C(%):  61.2
    Opt. T:  28℃
    Mid T(℃):  37(neg)
    NaCl 0.5-2%:  1(neg)
    Opt. pH:  6-8
    pH 6.0-8.0:  6.0(+)
    pH >8:  9.0(+)
    		Starch:  w
    SUBSTRATE ASSIMILATION & UTILISATION
    Monosaccharide util/assim Oligosaccharide util/assim Other carboh. util/assim Amino acid util/assim Organic acid util/assim
    Arabinose:  + L-Arabinose:  + Fructose:  + Galactose:  + Glucose:  + Mannose:  + Rhamnose:  + Ribose:  + Sorbose:  neg Xylose:  + Lactose:  + Melezitose:  neg Raffinose:  neg Sucrose:  + Trehalose:  + Dulcitol:  neg Erythritol:  + Gluconate:  + Inositol:  neg Inulin:  + Salicin:  neg Sorbitol:  + D-Ala:  + Arg:  + Asp:  neg Cys:  + Glu:  neg Gly:  neg Ile:  + Lys:  + Met:  + Phe:  neg Pro:  + Thr:  + Val:  + Acetate:  + Adipate:  neg Formate:  neg Pyruvate:  neg
    ENZYME ACTIVITY
    Enzymes: General Enzymes: Carbohydrate Enzymes: Protein Enzymes: Arylamidases Enzymes: Esters/fats
    Oxidase:  neg Catalase:  +
    METABOLITES - PRODUCTION & USE
    Fuel Usable Metabolites Metabolites Released Special Products Compounds Produced

    		H2S:  neg
    ANTIBIOTICS ℞
    Penicillins & Penems (μg/mL) Cephalosporins (μg/mL) Aminoglycosides (μg/mL) Macrolides (μg/mL) Quinolones (μg/mL)
    ampicillin:  S(5)
    gentamicin:  R(5)
    kanamycin:  R(5)
    neomycin:  S(50)
    spectinomycin:  S(5)
    streptomycin:  S(5)
    erythromycin:  R(300)
    Tetracyclines (μg/mL) Vancomycin Class (μg/mL) Polypep/ketides (μg/mL) Heterocycles (μg/mL) Other (μg/mL)
    tetracycline:  R(5)

    References

    SPECIFIC REFERENCES FOR MESORHIZOBIUM MULEIENSE
  • Zhang2012a - Mesorhizobium muleiense sp. nov., nodulating with Cicer arietinum L.
  • ...............................
    • GUT MICROBIOME COMPILATIONS AND METASTUDIES FOR MESORHIZOBIUM MULEIENSE
  • Byrd2020 - Stability and dynamics of the human gut microbiome and its association with systemic immune traits.
  • ...............................
    • Added: May 15, 2022